Search
for
Sort by
Research 391–420 of 1000+
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- TREATMENT OF SEVERE ALOPECIA AREATA USING METHOTREXATE AS AN ADJUNCTIVE DRUG IN COMBINATION WITH INTRAVENOUS AND ORAL CORTICOSTEROID
- Lignans and Neolignans: Plant secondary metabolites as a reservoir of biologically active substances
- Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery
- Geometric classification of scalp hair for valid drug testing, 6 more reliable than 8 hair curl groups
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Twist1 Contributes to the Maintenance of Some Biological Properties of Dermal Papilla Cells in vitro by Forming a Complex With Tcf4 and β-Catenin
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- In silico investigation of possible multi-target drugs against Glutamate S-transferase and prolyl tRNA synthetase in Onchocerca volvulus
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- Effects of Biotin - rich Functional Food (Whalgichan) on Hair Growth and Biological Stimulation in Rat and Human
- Graphene Oxide–IPDI–Ag/ZnO@Hydroxypropyl Cellulose Nanocomposite Films for Biological Wound-Dressing Applications
- Androgen receptor gene polymorphism and biological age markers in men
- Oil Body-Bound Oleosin-rhFGF-10: A Novel Drug Delivery System that Improves Skin Penetration to Accelerate Wound Healing and Hair Growth in Mice
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors
- Novel therapies for alopecia areata: The era of rational drug development
- The role of aquaporins in polycystic ovary syndrome – A way towards a novel drug target in PCOS
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- Microgel emulsion loaded with recombinant oil body as a new drug delivery carrier to promote wound repair
- Identification of neprilysin as a potential target of arteannuin using computational drug repositioning
- A Simple Decision Tree Suited for Identification of Early Oral Drug Candidates With Likely Pharmacokinetic Nonlinearity by Intestinal CYP3A Saturation
- Optimal concentration selection of active pharmaceutical ingredients in the cream-mask intended for androgenic alopecia treatment according to experimental results on paramecium caudatum biological model
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- A Review on Forensic Toxicological Analysis of Drugs in Hair using Various Instrumental Techniques
- Structures of three polycystic kidney disease-like domains from<i>Clostridium histolyticum</i>collagenases ColG and ColH